| 15.00 Delayed Data As of Apr 24 |  +0.09 / +0.60%Today’s Change | 14.04 Today|||52-Week Range 25.96 | -2.72% Year-to-Date |
| Amgen (AMGN) to Report Q1 Earnings: What's in the Cards? Apr 23 / Zacks.com - Paid Partner Content | Allergan Falls as Supreme Court Dismisses Restasis Litigation Apr 16 / Zacks.com - Paid Partner Content |
| Shelter Ins Retirement Plan Buys Activision Blizzard Inc, Sells Franklin Resources In... Apr 22 / GuruFocus News - Paid Partner Content | BioDelivery (BDSI) Buys US Rights to Pain Drug for $30M Apr 11 / Zacks.com - Paid Partner Content |
| Shelter Mutual Insurance Co Buys Activision Blizzard Inc, Sells Franklin Resources In... Apr 22 / GuruFocus News - Paid Partner Content |
| Previous close | 14.91 |
| Today’s open | 15.05 |
| Day’s range | 14.85 - 15.13 |
| Volume | 6,027,928 |
| Average volume (3 months) | 11,210,803 |
| Market cap | $15.5B |
| Earnings growth (last year) | +85.71% |
| Earnings growth (this year) | -18.43% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -16.69% |
| P/E ratio | NM |
| Price/Sales | 0.84 |
| Price/Book | 1.06 |
| Today’s change | Today’s % change | |
|---|---|---|
| BGNEBeiGene Ltd | -1.10 | -0.91% |
| AKRXAkorn Inc | -0.07 | -2.35% |
| OASMOasmia Pharmaceutica... | -0.10 | -4.41% |
| Next reporting date | May 2, 2019 |
| EPS forecast (this quarter) | $0.58 |
| Annual revenue (last year) | $18.8B |
| Annual profit (last year) | -$2.1B |
| Net profit margin | -11.40% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Kåre Schultz |
Executive Vice President- Global Operations Carlo de Notaristefani |
Corporate headquarters Petach Tikva, Hamerkaz |
